Loading...
Chemical structure of Lenvatinib

GC15454

Lenvatinib

Also listed as Lenvatinib (E7080)

E7080, known as lenvatinib, is an oral multitargeted tyrosine kinase inhibitor including VEGF, FGF and SCF receptors that has been shown to improve the survival rate of patients with radioiodine-refractory thyroid cancer

ChemicalCAS417716-92-8MW426.85FormulaC21H19ClN4O4
CAS number
417716-92-8
Molecular weight
426.85
Formula
C21H19ClN4O4
Solubility
DMSO： 8·33 mg/mL (15·93 mM)
InChIKey
WOSKHXYHFSIKNG-UHFFFAOYSA-N
Catalogue number
GC15454
Brand
GLPBIO
Computed properties PubChem CID 9823820 · XLogP 2.8 · TPSA 116 Ų · H-bond donors 3
XLogP
2.8
TPSA
116 Ų
H-bond donors
3
H-bond acceptors
5
Rotatable bonds
6
Heavy atoms
30

SMILES COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl

Computed descriptors from PubChem (CID 9823820), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.